Navigation Links
Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Date:1/12/2009

- Company to Provide Update on Pipeline Efforts at 27th Annual J.P. Morgan Healthcare Conference -

REDWOOD CITY, Calif., Jan. 12 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that it has initiated an independent clinical validation study for its 18-gene Oncotype DX(R) colon cancer assay. Utilizing more than 1,200 patient samples from the landmark QUASAR trial, the validation study will use prospectively defined endpoints to assess the clinical utility of the Oncotype DX colon cancer assay to predict likelihood of recurrence for stage II colon cancer patients treated with surgery alone and the magnitude of treatment benefit with chemotherapy following surgery. Results from the study are expected to be reported in the second half of 2009.

Stage II colon cancer (also known as Dukes' Stage B) affects an approximately 30-40,000 people each year in the United States and the current treatment paradigm is unclear. About a third of patients receive adjuvant chemotherapy, usually 5-fluorouracil/leucovorin (5FU/LV) or combinations that include 5FU/LV; however, research indicates that only 2-4 percent benefit from this treatment, which has significant associated toxicity. While there are existing clinical markers traditionally associated with higher-risk in colon cancer patients, there is no clinically validated genomic test available that predicts the likelihood of recurrence or magnitude of chemotherapy benefit for individual patients.

"There is a critical need for more targeted approaches in treating the tens of thousands of patients with stage II colon cancer and the initiation of this study brings us one step closer to delivering a tool that may do that," said Steven Shak, M.D., chief medical officer, Genomic Health. "Over the past two years we have partnered with the National Surgical
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
2. Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
3. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
4. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
5. Transgenomic Receives Accreditation From College of American Pathologists
6. Genomic Health Announces Appointment of Ginger Graham to Board of Directors
7. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
8. Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
9. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
10. Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products Neurodegenerative Diagnostics
11. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...ire-USNewswire/ -- Tomorrow, Corey Reich, an ALS p... the San Francisco Giants and Los Angeles Angels o...entative of the ALS Therapy Development Institute ...to raise awareness of amyotrophic lateral sclerose...disease of which he suffers and for which there is...
(Date:7/2/2009)...ewswire/ -- Advanced Chemical Transport, one of ... has announced a multi-year partnership with Gilea...-Med company. , , ACT will provide Environmenta...l, vacuum truck services, spill response, site spe... from its corporate headquarters in Sunnyvale, CA....
(Date:7/2/2009)...RNewswire-FirstCall/ -- Lixte Biotechnology Holdin... investigators of the National Institute of Neurol...al Cancer Institute (NCI), National Institutes of ... LB-1.2, enhances the effectiveness of two standar...ers. This research is being conducted under a Coop...
(Date:7/1/2009)...hnique that identifies and removes systematic bias...ental data could lead to more precise and reliable...ikely to have future industrial applications. , ...on (SPAR), the technique could also reduce the amo...ons, and help distinguish true nanoscale phenomena...
Breaking Biology Technology:Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th 2Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th 3Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 2Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models 3New statistical technique improves precision of nanotechnology data 2New statistical technique improves precision of nanotechnology data 3New statistical technique improves precision of nanotechnology data 4
...king the business world by storm, or so it would s... outsourcing topics featured in business and IT pu...ng to me to come across two recently released stud... firms - Deloitte Consulting and DiamondCluster -...agement practice. , ,Both of those studies inject ...
...hain technology provider, reported Friday that its...e-based division of Cooper Industries, to optimize...ivity. , ,The lighting manufacturer is replacing i...Warehouse, slotting and workforce performance mana...ication will provide improved picking and putaway ...
...ritain in 1940, Prime Minister Winston Churchill p...es against Nazi air power by saying, "Never in the...ny to so few." , ,If Churchill was around to descr... the Capitol office of Assembly Speaker John Gard,...cs were so many stereotypes and misperceptions rei...
... Business slows. Indeed, in Europe, where I find m...te of suspended animation that will last until the...ckons. Families cry out for attention. Work,s gras...away from e-mail, I returned to a Monday morning m...culously grown between 8 p.m. Friday and 7 a.m. Mo...
Other Biology Technology:Is outsourcing reaching its limits or simply pausing for breath? 2Is outsourcing reaching its limits or simply pausing for breath? 3Is outsourcing reaching its limits or simply pausing for breath? 4Delivery of needles in the Capitol missed the point about stem-cell research 2Delivery of needles in the Capitol missed the point about stem-cell research 3Leaving it all behind 2
(Date:7/2/2009)..., Researchers from the National Oceanography Cent...rth of oceanographic knowledge to investigate the ...ng crab. The results, published this week in the ... driving force behind the speciation and radiation...tens of millions of years of Earth,s history. , ...
(Date:7/2/2009)..., Scientists are to study a group of proteins tha...ch could hold the key to developing new types of a...of York and Leeds have been awarded 3.3m from the ...ncil (BBSRC) to find out how a family of proteins ...ells before destroying them. , The team, led by ...
(Date:7/1/2009)..., London, 1 July, 2009 Johnson & Johnson today a... Department of Molecular Biology at the Max Planck...veries have led to novel cancer therapies includin...009 Dr. Paul Janssen Award for Biomedical Research...ntists selected Dr. Ullrich, who on September 8 wi...
(Date:7/1/2009)..., , Deleting two genes in mice responsible for re...several types of tumors, providing additional evid...nt of cancer. That,s the conclusion of a recent st...l Institute of Standards and Technology (NIST), Or...New York University School of Medicine (NYUSM). ,...
Breaking Biology News(10 mins):Evolution: Crabs go deep to avoid hot water 2Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research 2Genetically engineered mice yield clues to 'knocking out' cancer 2MannKind Corporation Reports Second Quarter Financial Results 7078 1MannKind Corporation Reports Second Quarter Financial Results 7078 2MannKind Corporation Reports Second Quarter Financial Results 7078 3MannKind Corporation Reports Second Quarter Financial Results 7078 4MannKind Corporation Reports Second Quarter Financial Results 7078 5MannKind Corporation Reports Second Quarter Financial Results 7078 6Ethicon Endo Surgery to Acquire SurgRx 7075 1Ethicon Endo Surgery to Acquire SurgRx 7075 2Ethicon Endo Surgery to Acquire SurgRx 7075 3Stroke Risk Plummets With Healthy Lifestyle 25274 1Stroke Risk Plummets With Healthy Lifestyle 25274 2Run for Your Life 25271 1Run for Your Life 25271 2Run for Your Life 25271 3
...e webs of connections that few studies have been a... dies out. , Now, a Cornell study using computer s... a freshwater fish can affect the availability of ...Algae, at the base of the food chain, for example,...trients as nitrogen and phosphorus, which are othe...
...eloped mutualistic relationships with the plant vi...ulation much faster on virus-infected plants than ...art is unable to do so, according to the new resea... Academy of Agricultural Sciences, China. , Twenty... outbreaks of what is now known as whitefly (Bemis...
... are creating a technology that will allow doctors...e inside living humans and animals and watch their...d slither. , This high-resolution, high-speed im...for knee, shoulder, wrist and back injuries and he...movements, from the flight of birds to the leap of...
...to glow is helping researchers at the University o...lls that are critical for the proper functioning o...ker protein may shed light on brain cell defects b...eases. The researchers describe how this marker wo... Journal of Neuroscience. , The marker gives scien...
Other Biology News:Fish extinctions alter critical nutrients in water, study shows 2Whiteflies and plant viruses can help each other to speed up biological invasion 2Bones in motion: Brown scientists to create new 3-D X-ray system 2Bones in motion: Brown scientists to create new 3-D X-ray system 3Researchers develop marker that identifies energy-producing centers in nerve cells 2
...e derived from frozen embedded tissue blocks, whic...ures to ensure the highest quality. Tissues of eac...oned at a thickness of 7 microns and mounted on co...r) in comparison to core sections made using Tissu...
...is a completely redesigned and updated version of ...ll line of well-proven Alpha heat-pump assemblies....ance as the DNA Engine Dyad, and original Tetrad t...ls among platforms. The Tetrad 2 contains an onboa...
...ptors, 24 glass tubes (1.5 mm ID, 180 mm length), ...l and PROTEAN II XL wide-format cell offer the ver...luding SDS-PAGE, first- and second-dimension 2-D e...PAGE as well as high-resolution agarose electropho...
The SVT3-2 diverter valve is a 3-port, 2-position valve for use with the BioLogic DuoFlow system.
Biology Products: